- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Chinese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
8
High return on equity, past performance and sound balance sheet.
8 companies
Henan Lingrui Pharmaceutical
Market Cap: CN¥12.5b
Produces and sells medicines in China.
600285
CN¥22.07
7D
0.2%
1Y
-2.8%
Jiang Zhong PharmaceuticalLtd
Market Cap: CN¥14.6b
Engages in the manufacture of pharmaceutical products in China.
600750
CN¥23.19
7D
6.0%
1Y
11.8%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥42.5b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥95.90
7D
-1.8%
1Y
64.4%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.9b
Engages in the pharmaceutical business in China.
000915
CN¥33.49
7D
-2.9%
1Y
30.1%
WuXi AppTec
Market Cap: CN¥260.1b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥89.59
7D
-2.8%
1Y
74.3%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥30.9b
Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.
600329
CN¥46.37
7D
1.7%
1Y
46.1%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥17.6b
Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.
300573
CN¥73.46
7D
3.4%
1Y
22.5%
Shanghai Xiao Fang PharmaceuticalLtd
Market Cap: CN¥4.7b
Shanghai Xiao Fang Pharmaceutical Co.,Ltd.
603207
CN¥28.87
7D
-1.4%
1Y
11.4%